Kerry Noonan, BA

HEVA Business Partner
Sanofi, Cambridge, MA, 02141, USA

Poster(s):

• (240) Estimating the Economic Impact of Dupilumab in Type 2 Inflammatory Disease: Cost Offset Analysis of Atopic Dermatitis with Comorbid Asthma in the US Healthcare System
  Wednesday, October 29, 2025